Publication:
Preliminary results of the effectiveness and safety of tenofovir alefenamide fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy

Simple item page
dc.contributor.authorGÜNDÜZ, FEYZA
dc.contributor.authorDEMİRTAŞ, COŞKUN ÖZER
dc.contributor.authorsGÜNDÜZ F., DURAK S., ÜNSAL Y., DEMİR M., Ellik Z. M., YILDIRIM A. E., Mehdiyev S., ADANIR H., DEMİRTAŞ C. Ö., ÜÇBİLEK E., et al.
dc.date.accessioned2023-09-12T13:22:38Z
dc.date.accessioned2026-01-11T16:48:23Z
dc.date.available2023-09-12T13:22:38Z
dc.date.issued2022-07-01
dc.identifier.citationGÜNDÜZ F., DURAK S., ÜNSAL Y., DEMİR M., Ellik Z. M., YILDIRIM A. E., Mehdiyev S., ADANIR H., DEMİRTAŞ C. Ö., ÜÇBİLEK E., et al., "Preliminary results of the effectiveness and safety of Tenofovir Alefenamide Fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy", JOURNAL OF HEPATOLOGY, cilt.77, 2022
dc.identifier.issn0168-8278
dc.identifier.urihttps://hdl.handle.net/11424/293290
dc.identifier.volume77
dc.language.isoeng
dc.relation.ispartofJOURNAL OF HEPATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectMedicine
dc.subjectHealth Sciences
dc.subjectInternal Medicine Sciences
dc.subjectInternal Diseases
dc.subjectGastroenterology and Hepatology
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectGASTROENTEROLOGY & HEPATOLOGY
dc.subjectCLINICAL MEDICINE
dc.subjectClinical Medicine (MED)
dc.subjectHepatoloji
dc.subjectGastroenteroloji
dc.subjectHepatology
dc.subjectGastroenterology
dc.titlePreliminary results of the effectiveness and safety of tenofovir alefenamide fumarate prophylaxis in HBV-infected individuals, who received chemo/immunosuppressive therapy
dc.typearticle
dspace.entity.typePublication

Files

Collections

Araştırma Çıktıları